Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics

Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics

Accepted Manuscript Title: Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics Author: Getu Kahsay Huiying Song Ann Van Sche...

978KB Sizes 228 Downloads 386 Views

Accepted Manuscript Title: Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics Author: Getu Kahsay Huiying Song Ann Van Schepdael Deirdre Cabooter Erwin Adams PII: DOI: Reference:

S0731-7085(13)00161-1 http://dx.doi.org/doi:10.1016/j.jpba.2013.04.015 PBA 9037

To appear in:

Journal of Pharmaceutical and Biomedical Analysis

Received date: Revised date: Accepted date:

28-2-2013 10-4-2013 13-4-2013

Please cite this article as: G. Kahsay, H. Song, A. Van Schepdael, D. Cabooter, E. Adams, Hydrophilic interaction chromatography (HILIC) in the analysis of antibiotics, Journal of Pharmaceutical and Biomedical Analysis (2013), http://dx.doi.org/10.1016/j.jpba.2013.04.015 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

1

Hydrophilic interaction chromatography (HILIC) in the analysis

2

of antibiotics

3

Getu Kahsay, Huiying Song, Ann Van Schepdael, Deirdre Cabooter, Erwin Adams*

5 6

ip t

4

Laboratorium voor Farmaceutische Analyse, Faculteit Farmaceutische Wetenschappen, KU Leuven, O&N2, PB-923, Herestraat 49, B-3000 Leuven, Belgium

ABSTRACT

8

This paper presents a general overview of the application of hydrophilic interaction liquid

9

chromatography (HILIC) in the analysis of antibiotics in different sample matrices including

10

pharmaceutical, plasma, serum, fermentation broths, environmental water, animal origin,

11

plant origin, etc. Specific applications of HILIC for analysis of aminoglycosides, β-lactams,

12

tetracyclines and other antibiotics are reviewed. HILIC can be used as a valuable alternative

13

LC mode for separating small polar compounds. Polar samples usually show good solubility

14

in the mobile phase containing some water used in HILIC, which overcomes the drawbacks of

15

the poor solubility often encountered in normal phase LC. HILIC is suitable for analyzing

16

compounds in complex systems that elute near the void in reversed-phase chromatography.

17

Ion pair reagents are not required in HILIC which makes it convenient to couple with MS

18

hence its increased popularity in recent years. In this review, the retention mechanism in

19

HILIC is briefly discussed and a list of important applications is provided including main

20

experimental conditions and a brief summary of the results. The references provide a

21

comprehensive overview and insight into the application of HILIC in antibiotics analysis.

Ac ce p

te

d

M

an

us

cr

7

22 23

Keywords:

Antibiotics; HILIC; Retention mechanism

24 25

*Corresponding author. Tel: +3216323444; Fax: +3216323448 1

Page 1 of 60

26

E-mail address: [email protected]

27

Ac ce p

te

d

M

an

us

cr

ip t

28

2

Page 2 of 60

Contents

29

1. Introduction

30

2. Stationary and mobile phases for HILIC application 2.1. Stationary phases in HILIC

32

2.2. Mobile phases in HILIC

34

3. Use of HILIC for analysis of antibiotics 3.1. Aminoglycoside antibiotics

us

33

cr

31

ip t

28

3.1.1. Analysis of aminoglycosides

36

3.1.2. HILIC in the analysis of aminoglycosides

38

3.3. Tetracycline antibiotics

39

3.4. Other antibiotics

41

References

42 43 44 45

te

4. Conclusion

Ac ce p

40

M

3.2. Beta-lactam antibiotics

d

37

an

35

46 47 48 49 3

Page 3 of 60

49

1. Introduction Looking back into the history of liquid chromatography (LC), the pioneer systems were

51

operated in normal phase mode (NPLC) which implied that the stationary phase was polar.

52

Such stationary phase, however, exhibited heterogeneity that resulted in peak tailing and

53

non-linear retention factors with varying analyte concentrations [1]. Elution in NPLC has

54

been accomplished by non-polar organic solvents. Some variants like the use of isohydric

55

solvents were tried, but this approach was found to be rather tedious and failed to yield good

56

performance over a longer period [2-4]. The development of stationary phases for

57

chromatography driven by pharmaceutical studies of water/octanol partitioning, led to the

58

now well-established reversed phase (RP) systems [5, 6]. Bonded octadecyl stationary phases

59

allowed efficient separation of analytes within a broad range of polarity and fast column

60

equilibration. The lack of retention of highly hydrophilic compounds with ionizable

61

functional groups has been supplemented by ion exchange chromatography [7] or ion pairing

62

on RP columns [8]. However, for a large group of strongly hydrophilic compounds that could

63

not be ionized in solution, it was impossible to obtain retention on either stationary phase. The

64

problem has been overcome sometimes in GC by derivatization, and recently, in LC by

65

developing hydrophilic interaction chromatography (HILIC) [9].

67

cr

us

an

M

d

te

Ac ce p

66

ip t

50

The term “hydrophilic” refers to the affinity to water. The concept of HILIC is as follows:

68

a polar stationary phase retains polar analytes that are eluted by a mixture of organic solvent

69

(usually acetonitrile (ACN)) and water. HILIC is an alternative high-performance liquid

70

chromatography (HPLC) mode for separating polar compounds. HILIC has been reported as a

71

variant of NPLC, but the separation mechanism in HILIC is more complicated than that in 4

Page 4 of 60

72

NPLC [1, 10, 11]. While the acronym HILIC was first suggested by Alpert in 1990 [9], the

73

number of publications on HILIC has increased substantially since 2003 as indicated

74

elsewhere [11] and as outlined in the review by Hemström and Irgum [12].

75

charged basic groups in a solute led to pronounced hydrophilicity and retention. He

76

considered that the retention mechanism consisted mostly of partitioning between the bulk

77

mobile phase and a layer of mobile phase enriched with water, partially immobilized on the

78

stationary phase [9]. Hemström and Irgum [12] concluded that both adsorption and the

79

partitioning mechanism contribute to retention in HILIC. Models describing the retention

80

mechanism in HILIC can be found in references [10] and [13]. Like NPLC, HILIC employs

81

traditional polar stationary phases such as silica, amino or cyano, but the mobile phase used is

82

similar to those employed in the RPLC mode [9, 11, 12].

M

an

us

cr

ip t

Alpert noted that

d

83

Originally, HILIC was applied mainly for the determination of carbohydrates, amino

85

acids and peptides [10]. Since then, HILIC has been successfully applied to all types of liquid

86

chromatographic separations, including small molecules [14], pharmaceutical compounds

87

[15], metabolites [16], drugs of abuse [17], toxins [18], carbohydrates [19], oligosaccharides

88

[20], amino acids [21], peptides and proteins [9, 22]. The interest in the HILIC technique in

89

the last years has been promoted by growing demands for the analysis of polar drugs,

90

metabolites and biologically important compounds in proteomics, glycomics and clinical

91

analysis [23]. HILIC also allows the analysis of charged substances, as in ion chromatography

92

(IC). Another reason for the increasing popularity of HILIC is its excellent suitability for

93

coupling to mass spectrometry (MS). Fig. 1 shows how HILIC complements other areas of

94

chromatography and extends the range of separation options [11].

Ac ce p

te

84

5

Page 5 of 60

In general, advantages of HILIC have been summarized [24] as follows: (i) good peak

96

shapes can be obtained for bases, (ii) MS sensitivity is enhanced due to the high organic

97

content in the mobile phase and the high efficiency of spraying and desolvation techniques,

98

(iii) direct injection can often be made of extracts eluted from C18 solid-phase extraction

99

columns with solvents of high organic content, as these are weak solvents in HILIC, (iv) the

100

order of elution of solutes is different and generally the opposite of that found in RP

101

separations, (v) good retention of polar compounds is obtained in HILIC, whereas very poor

102

retention is often obtained in RPLC and (vi) higher flow rates are possible due to the high

103

organic content and hence lower viscosity of typical mobile phases. In addition, polar samples

104

always show good solubility in the water containing mobile phase used in HILIC, which

105

overcomes the drawbacks of the poor solubility often encountered in NPLC. Ion pair reagents

106

are not required in HILIC, and it can be conveniently coupled to MS, especially in the

107

electrospray ionization (ESI) mode. In contrast to RPLC, gradient elution HILIC begins with

108

a low-polarity organic solvent and elutes polar analytes by increasing the polar aqueous

109

content [25].

111

cr

us

an

M

d

te

Ac ce p

110

ip t

95

Other advantages of HILIC that have emerged more recently, include the use of long

112

columns to achieve highly efficient separations, a superior loading capacity to RP for charged

113

basic solutes and the potential of very fast analysis due to the good mass transfer

114

characteristics of the columns operated in mobile phases of much lower viscosity than

115

typically used in RPLC [24, 26]. Nevertheless, HILIC also has some drawbacks [27]

116

compared to RP separations which include: (i) the separation mechanism is at present less

117

well understood than that of RPLC. Thus, it may be difficult to predict the effect of a change 6

Page 6 of 60

in conditions on the separation outcome, (ii) the technique does not have the broad

119

applicability of RPLC. Analytes that are neutral and non-polar generally show very little

120

retention. In addition, ionised acidic analytes (negatively charged ions) can show little

121

retention due to repulsion of the ion from negatively charged column silanol groups on some

122

silica-based columns and (iii) HILIC is potentially an environmentally less friendly technique

123

than RPLC as it consumes much larger volumes of organic solvents.

cr

ip t

118

us

124

2. Stationary and mobile phases for HILIC applications

126

2.1. Stationary phases in HILIC

an

125

The chemical modification of silica gels using chemical reactions began in the 1960s.

128

Reaction between alkylsilyl chlorides and silanol groups (Si–OH) is the most common

129

method and was reported in 1970 [28]. Approximately at the same time as Alpert [9]

130

introduced the HILIC technique, Huber et al. [29] noted that the correct selection of a suitable

131

adsorbent is a crucial step for the success of so-called “solvent generated” liquid-liquid

132

chromatography, the category to which the HILIC mechanism can be attributed [30]. The

133

family of HILIC stationary phases with various support materials and surface chemistries has

134

continuously enlarged since, to suit specific separation problems. The basic types of HILIC

135

columns include plain silica, neutral, polar chemically bonded, ion-exchange and zwitterionic

136

stationary phases. NP separations on bare silica and amino-silica columns in aqueous-organic

137

mobile phases were reported as early as the mid-seventies [31]. Using neutral stationary

138

phases (e.g. diol and amide phases) there will be no electrostatic interactions, whereas with

139

charged phases (e.g. plain silica and aminopropyl phases) strong electrostatic interactions can

Ac ce p

te

d

M

127

7

Page 7 of 60

140

take place between the analytes and the stationary phase. Zwitterionic phases (e.g.

141

sulfobetaine silica) exhibit only weak electrostatic interactions with analytes [1]. The first separations in HILIC mode were reported in 1975. Linden et al. [31] separated

143

carbohydrates using an amino-silica phase, Bondapak (Waters, Milford, MA, USA) in a

144

mixture of ACN and water (75:25 v/v). The next generation of stationary phases for HILIC

145

used diol- and amide-silica. The diol-silica column has mainly been used for the separation of

146

proteins [32]. Amide-silica columns have been available since the mid-eighties. This

147

particular phase is described as consisting of non-ionic carbamoyl groups that are chemically

148

bonded to the silica gel, but is commonly known as an amide bonded silica. After Yoshida

149

[33] applied these phases for the separation of peptides, the amide-silica phase soon found

150

common usage in HILIC. Chemically bonded stationary phases with specific structural

151

properties have been prepared by Buszewski et al. [34, 35]. Since then silica hydride, hybrid

152

silica-organic phases and a large variety of silica-based or polymer HILIC columns have been

153

designed. Amide-, cyano-, diol-, polyethylene glycol-, poly(succinimide)- , sulfoalkylbetaine-,

154

cyclodextrin, pentafluorophenylpropyl, polyvinylalcohol, polypeptide and other polar

155

chemically bonded stationary phases have become available for HILIC separations, some of

156

them showing both HILIC and RP application possibilities [10]. Hence, the structural

157

variations of HILIC-type stationary phases are wider than those found in reversed-phase

158

systems. Table 1 shows a summary of the different structures of stationary phases that are

159

applicable to HILIC-mode separation [11].

Ac ce p

te

d

M

an

us

cr

ip t

142

160 161

Chirita et al. [36] suggested a good scheme for column selection and applied it to the

162

analysis of neurotransmitters. In terms of the retention characteristics and selectivity, their 8

Page 8 of 60

column selection method seems to be acceptable but the separation efficiency must be

164

considered too. The characterization of HILIC stationary phases has been reported, but there

165

is no test scheme to describe the structure selectivity relationships for HILIC phases, in

166

contradistinction with the well-accepted column tests for RP stationary phases [37–40].

167

Kawachi et al. [41] suggested an inclusive test scheme of HILIC stationary phases using

168

trimethylphenylammonium chloride, sodium p-toluenesulfonate, nucleosides, saccharides,

169

and xanthines to describe the degree of hydrophilicity, the selectivity for hydrophilic and

170

hydrophobic groups, positional selectivity and the configuration of hydrophilic groups, the

171

anion and cation exchange properties, the local pH conditions on the stationary phases and the

172

shape selectivity. In this test scheme, it was possible to divide the HILIC phases into several

173

groups with varying selectivity. This can be helpful to select stationary phases in combination

174

with the structural characteristics of the target analyte.

d

M

an

us

cr

ip t

163

177

2.2. Mobile phases in HILIC

Ac ce p

176

te

175

A typical mobile phase for HILIC chromatography includes water-miscible polar organic

178

solvents with a small amount of water [9]. Although the retention mechanism in HILIC is not

179

completely understood, it is supposed to be caused by partitioning. This mode is based on the

180

differential distribution of the injected analyte molecules between the organic-rich mobile

181

phase and a water-enriched layer adsorbed onto the hydrophilic stationary phase. The more

182

hydrophilic the analyte, the more the partitioning equilibrium is shifted towards the

183

immobilized water layer on the stationary phase, and thus, the more the analyte is retained [9,

184

12].

185 9

Page 9 of 60

Usually, ACN is used as organic solvent, but any aprotic solvent that is miscible with

187

water (e.g., tetrahydrofuran, THF) can be used. Alcohols can also be adopted, although a

188

higher concentration is needed to achieve the same degree of retention of the analyte relative

189

to an aprotic solvent–water combination [12]. HILIC on polar stationary phases employs

190

organic-rich mobile phases, usually containing 5–40% water or a volatile buffer if used in

191

combination with MS or charged aerosol detection. Mobile phase pH and ionic strength

192

significantly affect the retention and separation selectivity of ionisable analytes in HILIC

193

separations which can be detrimental for the robustness. Buffer salts and mobile phase

194

additives such as ammonium acetate, ammonium formate, ammonium phosphate and

195

trifluoroacetic acid are commonly used to improve peak shape and to control analyte polarity

196

so as to effect differential changes in retention. However the positive impact of mobile phase

197

pH and ionic strength on a separation also depends on the properties of the stationary phase

198

[10, 11]. It is recommended to perform initial experiments at a relatively high concentration

199

(e.g., 40%) of aqueous buffer in ACN, to ensure the elution of all sample compounds. Then

200

the elution strength is adjusted by increasing the concentration of ACN, until acceptable

201

sample retention is achieved. Alternatively, a scouting gradient of decreasing ACN

202

concentration can be run. Gradients with high initial concentration of organic modifier and

203

increasing concentrations of water were successfully applied for HILIC separations of various

204

biological samples, especially with bare silica columns. The gradient usually starts from 95%

205

ACN containing 5% aqueous ammonium acetate or ammonium formate buffer, with gradually

206

decreasing ACN concentration. Running the gradient up to a high water concentration (up to

207

90%) may help removing strongly retained sample interferences [10].

Ac ce p

te

d

M

an

us

cr

ip t

186

10

Page 10 of 60

In HILIC water acts as the strong solvent, hence the higher the organic content the greater

209

the retention of the polar analytes will be [42]. For this reason, solvents typically used in

210

HILIC contain 60–90% of organics and are thus suitable for LC/MS analysis using ESI,

211

without significant changes in ionization efficiency during gradient elution [1, 42]. In mobile

212

phases containing some water, the preferential adsorption causes formation of a water-rich

213

adsorbed liquid multi-layer (Fig. 2). In aqueous-organic NP containing more than 0.5–1%

214

water, the layer of adsorbed water is thick enough to induce liquid-liquid partition between

215

the bulk mobile phase and the adsorbed aqueous liquid layer. However, sample adsorption on

216

polar surface centers may significantly contribute to the retention [10]. The NPLC drawback

217

of insolubility of hydrophobic compounds is largely solved in HILIC because of its mobile

218

phase properties. It often provides sufficient retention of strongly polar compounds, for which

219

it offers different selectivity compared to traditional RP chromatography [9, 43].

cr

us

an

M

d

te

220

ip t

208

The selection of the organic solvent in HILIC has a strong effect on the retention. The

222

elution strength of organic solvents in the HILIC mode increases generally in the order of

223

increasing solvent polarity and ability to participate in proton-donor/proton-acceptor

224

interactions: methanol > ethanol > 2-propanol > THF > ACN [43]. ACN is strongly preferred

225

as the organic compound because mobile phases containing other solvents often provide

226

insufficient sample retention and broad or non-symmetrical peak shapes [10]. Another

227

interesting organic solvent to be used in the mobile phase is THF, which is a strong hydrogen

228

bond acceptor which may result in a different analyte elution order than ACN. Polar protic

229

solvents, such as methanol, ethanol or isopropanol can act as both hydrogen bond donors and

230

acceptors and can compete for active polar sites on the HILIC surface. Therefore analytes,

Ac ce p

221

11

Page 11 of 60

whose retention is based on strong hydrogen bonding, are poorly retained. Approaches for

232

method development in HILIC have been extensively discussed in a publication by Dejaegher

233

et al. [44].

235

3. Use of HILIC for analysis of antibiotics

237

3.1. Aminoglycoside antibiotics

238

3.1.1. Analysis of aminoglycosides

us

236

cr

234

ip t

231

Aminoglycosides (AGs) are very polar and lack chromophores (neomycin B is shown as

240

an example in Fig. 3), which makes them difficult to separate using conventional RPLC with

241

UV detection. Researchers have overcome this problem by employing derivatization agents

242

and ion-pair reagents for detection [53-63]. However, derivatization steps make the analytical

243

process more time consuming and often give problems with quantitation. HILIC combined

244

with MS has been receiving great attention for AGs analysis as there is no need for

245

derivatization or addition of ion-pairing reagents.

247 248

M

d

te

Ac ce p

246

an

239

3.1.2. HILIC in the analysis of aminoglycosides HILIC has been widely used to analyze aminoglycosides in different matrices (Table 2),

249

including muscle and kidney [64, 65], plasma [66], serum [67, 68], manure [69], apples [70],

250

milk [71], honey [72] and bulk samples [73]. Kumar et al. [72] reported a HILIC method for

251

the analysis and investigation of the chromatographic behavior of several AGs (streptomycin,

252

dihydrostreptomycin, spectinomycin, apramycin, neomycin, paramomycin, kanamycin A and

253

gentamicins). Stationary phases with three different charge states, such as bare silica 12

Page 12 of 60

(negative), aminopropyl (positive), amide (neutral) and ZIC HILIC (zwitterionic), were

255

chosen for the screening experiments. Mobile phase constituents (pH and ionic strength) and

256

column temperature were also investigated. The zwitterionic HILIC provided the most

257

satisfactory separation and sensitivity. The method was directly applicable for the analysis of

258

AG residues in honey. Based on these research results, Kumar et al. [74] continued to study

259

AG residues in kidney samples from food-producing animals and in honey samples by

260

zwitterionic HILIC in combination with a triple quadrupole mass analyzer. The LOQ ranged

261

from 2 to 125 µg/kg in honey and 25 to 264 µg/kg in kidney samples, which is well below the

262

maximum residue limits (MRLs) established. Also in other studies zwitterionic HILIC

263

stationary phases were found to perform well [64, 67, 68, 72, 74]. Six AGs (amikacin,

264

gentamicin, kanamycin, neomycin, paromomycin and tobramycin) were simultaneously

265

quantified by ZIC HILIC combined with ESI-MS/MS detection in human serum [67].

266

Similarly, neomycin was quantitated by LC-MS/MS using HILIC in human serum [68].

267

Analysis of neomycin, apramycin and kanamycin was possible by zwitterionic HILIC with

268

MS detection and the same column was also successfully employed in a retention mechanism

269

study (Fig. 4) [75].

270

built up when equilibrating the stationary phase with the mobile phase. A polar analyte will

271

experience hydrophilic partitioning between the water layer and the mobile phase. Besides, a

272

charged analyte may have weak and/or strong electrostatic interactions (both attraction and

273

repulsion) by the zwitterionic groups, which greatly contribute to the separation [10]. Since

274

the AGs have strong electrostatic interaction with the zwitterionic stationary phase, it is

275

necessary to use formic acid and a high buffer concentration in the mobile phase to achieve

Ac ce p

te

d

M

an

us

cr

ip t

254

A crucial part in the separation mechanism is a water layer, which is

13

Page 13 of 60

276

good chromatographic performance.

277

Multi-residue AG antibiotics in bovine and porcine muscle and kidney were quantitated

279

using LC-MS/MS [64]. A ZIC-HILIC column was employed for the chromatographic

280

separation. The method was found to be sensitive, robust and highly specific for the

281

simultaneous quantification of the AGs with LOQs of 25 ng/g for gentamicin, 50 ng/g for

282

spectinomycin, dihydrostreptomycin, kanamycin and apramycin; and 100 ng/g for

283

streptomycin and neomycin, which are all well below the maximum residue limits set by the

284

Codex Alimentarius Commission [64].

an

us

cr

ip t

278

285

Streptomycin (STR) and dihydrostreptomycin (DHSTR) are two of the most commonly

287

used AG antibiotics in veterinary medicine. Gremilogianni et al. [71] compared HILIC with

288

ion-pair chromatography (IPC) for the determination of STR and DHSTR residues in milk.

289

Comparison of the validation parameters (sensitivity, precision and recovery) of these two

290

methods revealed superiority for the HILIC method (Table 3). HILIC separation was

291

performed using a silica based HILIC Fortis column. The sensitivity of the HILIC method

292

was greater than that of the IPC method for both STR and DHSTR.

294

d

te

Ac ce p

293

M

286

A HILIC-MS/MS method for detection and quantification of spectinomycin and

295

lincomycin from liquid manure and rainfall run-off was described by Peru et al. [69]. The

296

chromatographic separation was performed on a silica-based Altima HP HILIC column. MS

297

detection was carried out using an atmospheric pressure chemical ionization (APCI) interface

298

in multiple reaction monitoring (MRM) positive ion mode. They found that the method was

299

sensitive for the quantification of the antibiotics and that HILIC provided excellent retention 14

Page 14 of 60

300

and separation of spectinomycin and lincomycin from interfering matrix components without

301

the need for ion-pairing reagents.

302

An automated LC-MS/MS method using a CAPCELL PAK ST HILIC column for the

304

simultaneous quantification of 15 AGs residues in muscle, liver (pigs, chicken and cattle),

305

kidney (pigs and cattle), cow milk and hen eggs was reported elsewhere [65]. The 15 AGs

306

consist of streptomycin (STREP), amikacin (AMIKA), hygromycin B (HYGRO),

307

dihydrostreptomycin (DIHY), netilmicin (NETIL), kasugamycin (KASUG), kanamycin B

308

(KANA), sisomicin (SISO), spectinomycin (SPECT), gentamicin C1 (GENT), apramycin

309

(APRA), paromomycin (PAROM), tobramycin (TOBRA), ribostamycin (RIBOS) and

310

neomycin B (NEOM). The detection capabilities in this method ranged from 10 to 50 µg/kg.

311

The MRM LC-MS/MS chromatograms of the extractions of blank bovine liver spiked with

312

these AGs are shown in Fig. 5. The report concluded that the LC-MS/MS method could be

313

applied to trace analysis of multi-component AG contaminants in complex sample matrices.

314

The HILIC method gave satisfactory retention and separation of the AGs residues.

315 316 317

3.2.

Ac ce p

te

d

M

an

us

cr

ip t

303

Beta-lactam antibiotics

Penicillins and cephalosporins have been thoroughly investigated in RP-HPLC systems

318

coupled with different methods of detection such as UV detection [76, 77], MS [78, 79] or

319

chemiluminescence detection [80]. Since these compounds are rather small polar molecules,

320

they could hardly be analyzed in RP-HPLC mode. Ion-pairing reagents, buffers and acids are

321

often used as additives [81-83] to improve the retention and peak shape [84]. In addition,

322

multidimensional [85] and capillary HPLC systems have been developed to analyze 15

Page 15 of 60

cephalosporins at lower concentrations in different sample matrices [86]. Some

324

cephalosporins were used as model substances in mixtures with other drugs in HILIC mode,

325

but their particular chromatographic retention was not explained [23, 87]. It is reported that

326

HILIC was also used to analyze cephalosporin C [88, 89].

ip t

323

327

The simple mobile phase of HILIC and its compatibility with MS opened a new door for

329

the analysis of cephalosporins. Liu et al. [88] developed a HILIC method to separate seven

330

commonly used cephalosporins (cefotaxime sodium, cefpiramide, cefazolin sodium, cefepime

331

hydrochloride, cefixime, ceftazidime and ceftriaxone sodium). Chromatograms for the 7

332

cephalosporins on the Click β-CD column and Atlantis HILIC silica column are shown in Fig.

333

6. The orthogonality between HILIC and RPLC for cephalosporins was also investigated. The

334

authors further developed a successful HILIC method to analyze cefotaxime sodium and its

335

degradation products. A HILIC-MS/MS method for the simultaneous determination of three

336

polar, non-structurally related compounds – (1) a carbapenem antibiotic, imipenem (IMP), (2)

337

a renal dehydropeptidase inhibitor, cilastatin (CIL) and (3) an investigational β-lactamase

338

inhibitor MK-4698 (BLI) – in biological fluids was described elsewhere [89].

339

HILIC-ESI-MS/MS method for the multitarget quantitative analysis of the hydrophilic

340

metabolites of penicillins and cephalosporins has also been described [90]. Jovanović et al.

341

[91] reported the chromatographic behaviour of mixture of β-lactam antibiotics (Cefotaxime,

342

cefalexin, cefaclor, cefuroxime, cefuroxime axetil, ampicillin and amoxicillin) using

343

HILIC-UV and their retention prediction models were designed by applying Box-Behnken

344

Design. Beta-lactam antibiotics analyzed using HILIC with different detection systems are

345

summarized in Table 4.

Ac ce p

te

d

M

an

us

cr

328

A

16

Page 16 of 60

346

3.3. Tetracycline antibiotics Tetracycline antibiotics (TCs) are a large class of antibiotics that characteristically contain

348

an octahydronaphthacene ring skeleton with four fused rings. The various TCs mainly differ

349

in their substitution groups at the C5, C6 and C7 positions and include tetracycline (TC),

350

chlortetracycline (CTC), doxycycline (DC) and oxytetracycline (OTC) (Fig.7).

cr

ip t

347

351

Analysis methods of TCs over the past twenty years have been reviewed [92, 93-98].

353

Among them, LC using a C18 or C8 column, with UV, fluorometry and mass spectrometry

354

detection are generally preferred. However, owing to the presence of two ketone groups in

355

positions 1 and 11, and the enols around C10 and C12, TCs can readily chelate with trace

356

metal ions present in silica packing material or from the equipment. Most of them have a

357

strong tendency to irreversibly bind to the silanol groups in a silica-based packing column. As

358

a result, this causes severe tailing of TCs peaks [99-102]. In order to avoid this problem,

359

adding chelating agents, such as oxalic acid and EDTA salts to the mobile phase and RP

360

end-capped columns have been employed. Using HILIC silica with high purity silica columns,

361

non-selective reactions such as complex formation or ion effects leading to less favorable

362

separations could be prevented [103, 104].

364

an

M

d

te

Ac ce p

363

us

352

TCs are not only widely used as veterinary medicines, but also as growth additives in

365

animal feeds or water [92]. It has been reported that only a small portion of the applied TCs

366

(veterinary or food additives) is metabolized or absorbed in animals and most of the

367

unmetabolized form is released in excreta [105], which enters into the environment and

368

disrupts the indigenous microbial population. Therefore, many researchers focus on the 17

Page 17 of 60

development of a rapid and sensitive method for the determination of TCs in the environment.

370

Li et al. [106] reported the environmental fate and transport of four zwitterionic TCs

371

(oxytetracycline, doxycycline, chlortetracycline and tetracycline) and developed a

372

HILIC-MS/MS method for detection and quantification of these antibiotics in environmental

373

waters. The chromatographic separation was achieved on an amino-bonded silica HILIC

374

column under isocratic conditions. During method development, the effects of mobile phase

375

components (buffer type, pH and type and concentration of organic modifier) on retention and

376

separation of TCs on the column was investigated and a mixed-mode retention mechanism

377

composed of partitioning, adsorption and ion-exchange interaction was proposed.

an

us

cr

ip t

369

M

378

Determination of OTC, TC and CTC in different sample matrices using a HILIC or mixed

380

HILIC-ion exchange mode were also described elsewhere [107, 108]. The methods gave rapid

381

and robust separations of the TCs. HILIC using high-purity silica as stationary phase has been

382

applied for the separation of epirubicin and its analogues [109]. Several parameters affecting

383

the chromatographic behavior such as organic modifier, buffer pH and ion strength have been

384

investigated. Of utmost importance for successful separation of the analogues (doxorubicin,

385

daunorubicin and epidaunorubicin) is the choice of organic modifier. ACN was shown to offer

386

superior separation to methanol, isopropanol or THF. Table 5 summarizes the application of

387

HILIC for TCs in different sample matrices.

Ac ce p

te

d

379

388 389

3.4. Other antibiotics

390

Besides β-lactams, AGs and TCs, HILIC has been widely employed for the analysis of

391

other antibiotics (Table 6). Although RPLC is the predominant LC mode applied to peptide 18

Page 18 of 60

separation, there is a growing awareness of the potential of HILIC as a complementary mode

393

in situations where RPLC does not offer the required retention and overall separation

394

efficiency. Determination of the glycopeptide antibiotic avoparcin in kidney using a 200Å, 5

395

µm HILIC column was reported by Curren and King [110]. Van Dorpe et al. [111] reported

396

HILIC analysis of peptide antibiotics (vancomycin and polymyxin) using Alltima HP and ZIC

397

HILIC columns. Determination of 13 sulfonamide antibacterials in milk and eggs using the

398

polymer monolith microextraction (PMME) technique was also possible [112] on a Luna NH2

399

HILIC column followed by MS detection.

400

carbadox and olaquindox with matrix solid-phase dispersion (MSPD) extraction in swine feed

401

using a BEH HILIC column [113] and bicozamycin using a TSK-GEL NH2 HILIC column

402

and MS detection [114] showed to be successful with greater separation efficiency. Analysis

403

of levofloxacin in human plasma using an Atlantis HILIC silica column and determination of

404

gemifloxacin on dried blood samples using

405

reported [115, 116] and the methods were successfully applied for pharmacokinetic studies of

406

these drugs.

408 409

us

cr

te

d

M

an

Quantification of antibacterial drugs like

a ZIC-HILIC C18 column have also been

Ac ce p

407

ip t

392

4. Conclusion

The use of HILIC for the analysis of antibiotics is reviewed. In recent years, the HILIC

410

separations have received greater attention mainly due to their versatility for the analysis of

411

polar drugs, metabolites, biologically important compounds, etc. in complex sample matrices

412

of different origin. Due to the very hydrophilic nature of most antibiotics, HILIC is more

413

suitable for the analysis of antibiotics compared to traditional RP chromatography. There are 19

Page 19 of 60

414

many kinds of HILIC columns available on the market with diverse stationary phases.

415

However, bare silica, zwitterionic and aminopropyl based stationary phases are most

416

commonly used.

417

separation of most antibiotics. The on-going developments of new HILIC methods in

418

conjunction with more powerful detection systems will probably increase its use and

419

popularity in antibiotics analysis in the future.

us

cr

ip t

ESI-MS/MS is the most popular detection method employed in HILIC

420

an

421 422

M

423

427 428 429 430 431

te

426

Ac ce p

425

d

424

432 433 434 435 20

Page 20 of 60

Figure legends

437

Fig. 1. HILIC as a complement to normal phase and reversed phase LC separations.

438

Fig. 2. Schematic picture of an adsorbed diffuse water layer at the surface of a polar stationary

439

phase in highly organic environment. Figure adapted from [10].

440

Fig. 3. Chemical structure of neomycin B

441

Fig. 4. Retention of polar/hydrophilic compounds on a zwitterionic HILIC stationary phase.

cr

Figure adapted from [75].

us

442

ip t

436

Fig. 5. MRM LC-MS/MS chromatograms of the extractions of blank bovine liver spiked with

444

AGs equivalent to detection capabilities of 20 µg/kg for APRA, STREP, DIHY, SPECT,

445

GENT, TOBRA, PAROM, HYGRO, RIBOS, KASUG, AMIKA, NEOM, KANA, SISO,

446

NETIL. Figure adapted from [65].

d

447

M

an

443

Fig. 6. Chromatograms for seven cephalosporins on the Click β-CD column (a) and Atlantis

449

HILIC Silica column (b, c). Mobile phase: A, 10 mM ammonium formate at pH 6.8; B,

450

ACN-100 mM ammonium formate = 90:10 at pH 6.8. Gradient for (a) and (b) was

451

88%–65%B in 20 min and 65%B in the next 10 min; gradient for (c) was 100%–75%B in 20

452

min and 75%B in the next 15 min. (1) Cefotaxime sodium, (2) cefpiramide, (3) cefazolin

453

sodium, (4) cefepime hydrochloride, (5) cefixime, (6) ceftazidime and

454

sodium. Figure adapted from [88].

Ac ce p

te

448

(7) ceftriaxone

455 456

Fig. 7. Structure of some tetracyclines

457 458 21

Page 21 of 60

459 460 461

References [1] J. Bernal, A.M. Ares, J. Pól, S.K. Wiedmer, Hydrophilic interaction liquid chromatography in food analysis, J. Chromatogr. A, 1218 (2011) 7438–7452.

ip t

462

[2] J.-P. Thomas, A. Brun, J.-P. Bounine, Isohydric solvents in liquid-solid column

464

chromatography: Importance for the reproducibility of chromatographic separations

465

and application to the experimental determination of mobile phase polarity, J.

466

Chromatogr. A, 139 (1977) 21–43.

an

467

us

cr

463

[3] G.A. Bens, E. Crombez, P. De Moerloose, Applications of a modified “Isohydric

469

solvent system” in HPLC on silica gel for the analysis of the macrolide antibiotics

470

turimycins and spiramycins, J. Liq. Chromatogr. 5 (1982) 1449–1465.

M

468

474

te

473

[4] P. Jandera, J. Churáček, Gradient elution in column liquid chromatography: Theory and Practice, J. Chromatogr. Library-Vol. 31, Elsevier, Amsterdam, 1985.

Ac ce p

472

d

471

475

[5] K. Valkó, L.R. Snyder, J.L. Glajch, Retention in reversed-phase liquid

476

chromatography as a function of mobile-phase composition, J. Chromatogr. A 656

477 478 479 480

(1993) 501–520.

[6] J.G. Dorsey, M.G. Khaledi, Hydrophobicity estimations by reversed-phase liquid chromatography, J. Chromatogr. A 656 (1993) 485–499.

481 482 483

[7] A. Nordborg, E.F. Hilder, Recent advances in polymer monoliths for ion-exchange chromatography, Anal. Bioanal. Chem. 394 (2009) 71–84. 22

Page 22 of 60

484

[8] J. Dai, P.W. Carr, Effect of mobile phase anionic additives on selectivity, efficiency,

485

and sample loading capacity of cationic drugs in reversed-phase

486

chromatography, J. Chromatogr. A 1216 (2009) 6695–6705.

489

[9] A.J. Alpert, Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds, J. Chromatogr. 499 (1990) 177–196.

cr

488

ip t

487

490

review, Anal. Chim. Acta 692 (2011) 1–25.

493

497 498 499 500

M

[12] P. Hemström, K. Irgum, Hydrophilic interaction chromatography, J. Sep. Sci. 29

d

496

powerful separation technique, Anal. Bioanal. Chem. 402 (2012) 231–247.

(2006) 1784–1821.

te

495

[11] B. Buszewski, S. Noga, Hydrophilic interaction liquid chromatography (HILIC)—a

[13] Y. Guo, S. Gaiki, Retention and selectivity of stationary phases for hydrophilic

Ac ce p

494

us

492

[10] P. Jandera, Stationary and mobile phases in hydrophilic interaction chromatography: a

an

491

liquid

interaction chromatography, J. Chromatogr. A 1218 (2011) 5920–5938.

501

[14] Y. Hsieh, J. Chen, Simultaneous determination of nicotinic acid and its metabolites

502

using hydrophilic interaction chromatography with tandem mass spectrometry, Rapid

503

Commun. Mass Spectrom. 19 (2005) 3031–3036.

504

[15] B.A. Olsen, Hydrophilic interaction chromatography using amino and silica columns

505

for the determination of polar pharmaceuticals and impurities, J. Chromatogr. A 913

506

(2001) 113–122. 23

Page 23 of 60

507 508

[16] Y. Hsieh, Potential of HILIC-MS in quantitative bioanalysis of drugs and metabolites, J. Sep. Sci. 31 (2008) 1481–1491. [17] A. Gheorghe, A. van Nuijs, B. Pecceu, L. Bervoets, P.G. Jorens, R. Blust, H. Neels, A.

510

Covaci, Analysis of cocaine and its principal metabolites in waste and surface water

511

using solid-phase extraction and liquid chromatography–ion trap tandem mass

512

spectrometry, Anal. Bioanal. Chem. 391 (2008) 1309–1319.

us

cr

ip t

509

[18] C. Dell`Aversano, P. Hess, M.A. Quilliam, Hydrophilic interaction liquid

514

chromatography–mass spectrometry for the analysis of paralytic shellfish poisoning

515

(PSP) toxins, J. Chromatogr. A 1081 (2005) 190–201.

M

an

513

[19] S.C. Churms, Recent progress in carbohydrate separation by high-performance liquid

517

chromatography based on hydrophilic interaction, J. Chromatogr. A 720 (1996) 75–91.

518

[20] G.O. Staples, M.J. Bowman, C.E. Costello, A.M. Hitchcock, J.M. Lau, N. Leymarie, C.

519

Miller, H. Naimy, X. Shi, J. Zaia, A chip-based amide-HILIC LC/MS platform for

te

Ac ce p

520

d

516

glycosaminoglycan glycomics profiling, Proteomics 9 (2009) 686–695.

521

[21] T. Langrock, P. Czihal, R. Hoffmann, Amino acid analysis by hydrophilic interaction

522

chromatography coupled on-line to electrospray ionization mass spectrometry, Amino

523

Acids 30 (2006) 291–297.

524

[22] P.J. Boersema, N. Divecha, A.J. Heck, S. Mohammed, Evaluation and optimization of

525

ZIC-HILIC-RP as an alternative MudPIT strategy, J. Proteome. Res. 6 (2007)

526

937–946. 24

Page 24 of 60

[23] M.A. Strege, Hydrophilic interaction chromatography-electrospray mass spectrometry

528

analysis of polar compounds for natural product drug discovery, Anal. Chem. 70

529

(1998) 2439–2445.

ip t

527

[24] D.V. McCalley, Is hydrophilic interaction chromatography with silica columns a viable

531

alternative to reversed-phase liquid chromatography for the analysis of ionisable

532

compounds?, J. Chromatogr. A 1171 (2007) 46–55.

us

cr

530

533

[25] S. Cubbon, T. Bradbury, J. Wilson, J. Thomas-Oates, Hydrophilic interaction

535

chromatography for mass spectrometric metabonomic studies of urine, Anal. Chem. 79

536

(2007) 8911–8918.

M

an

534

[26] D.V. McCalley, Evaluation of the properties of a superficially porous silica stationary

538

phase in hydrophilic interaction chromatography, J. Chromatogr. A 1193 (2008)

539

85–91.

te

d

537

[27] D. V. McCalley, The challenges of the analysis of basic compounds by high

541

performance liquid chromatography: some possible approaches for improved

542

Ac ce p

540

separations, J. Chromatogr. A 1217 (2010) 858–880.

543

[28] T. Ikegami, K. Tomomatsu, H. Takubo, K. Horie, N. Tanaka, Separation efficiencies in

544

hydrophilic interaction chromatography, J. Chromatogr. A 1184 (2008) 474 – 503.

545 546

[29]

J.F.K. Huber, M. Pawlowska, P. Markl, Selection of the solid support–a crucial step

547

for the realization of solvent generated liquid-liquid chromatography, J. Chromatogr. A

548

500 (1990) 257–280. 25

Page 25 of 60

549 550

[30] J.F.K.

Huber,

M.

Pawlowska,

P.

Markl,

Solvent-generated

liquid-liquid

chromatography with aqueous ternary systems, Chromatographia 19 (1984) 19–28.

551

555 556 557

ip t cr

554

105 (1975) 125–133.

[32] M. Rubinstein, Preparative high-performance liquid partition chromatography of proteins, Anal. Biochem. 98 (1979) 1–7.

us

553

[31] J.C. Linden, C.L. Lawhead, Liquid chromatography of saccharides, J. Chromatogr. A

[33] T. Yoshida, Prediction of peptide retention time in normal-phase liquid

an

552

chromatography, J. Chromatogr. A 811 (1998) 61–67.

558

[34] B. Buszewski, M. Jezierska-Świtała, S. Kowalska, Stationary phase with specific

560

surface properties for the separation of estradiol diastereoisomers, J. Chromatogr. B

561

792 (2003) 279–286.

te

562

564 565 566

[35] S. Kowalska, K. Krupczyńska, B. Buszewski, The influence of the mobile phase pH

Ac ce p

563

d

M

559

and the stationary phase type on the selectivity tuning in high performance liquid chromatography nucleosides separation, J. Sep. Sci. 28 (2005) 1502–1511.

567

[36] R.I. Chirita, C. West, A.L. Finaru, C. Elfakir, Approach to hydrophilic interaction

568

chromatography column selection: application to neurotransmitters analysis, J.

569

Chromatogr. A 1217 (2010) 3091–3104.

570

[37] E. Cruz, M.R. Euerby, C.M. Johnson, C.A. Hackett, Chromatographic classification of

571

commercially available reverse-phase HPLC columns, Chromatographia 44 (1997)

572

151–161. 26

Page 26 of 60

573 574

[38] U.D. Neue, K. Van Tran, P.C. Iraneta, B.A. Alden, Characterization of HPLC packings, J. Sep. Sci. 26 (2003) 174–186. [39] D. Visky, E. Haghedooren, P. Dehouck, Z. Kovács, K. Koczian, B. Noszál, J.

576

Hoogmartens, E. Adams, Faccilitated column selection in pharmaceutical analyses

577

using a simple column classification system, J. Chromatogr. A, 1101 (2006) 103–114.

579

cr

[40] K. Kóczián, E. Haghedooren, S.Dragovic, B. Noszál, J. Hoogmartens, E. Adams, J. Pharm. Biomed. Anal. 44 (2007) 894–905.

an

580

us

578

ip t

575

[41] Y. Kawachi, T. Ikegami, H. Takubo, Y. Ikegami, M. Miyamoto, N. Tanaka,

582

Chromatographic characterization of hydrophilic interaction liquid chromatography

583

stationary phases: Hydrophilicity, charge effects, structural selectivity, and separation

584

efficiency, J. Chromatogr. A 1218 (2011) 5903–5919.

te

d

M

581

[42] Z. Hao, B. Xiao, N. Weng, Impact of column temperature and mobile phase

586

components on selectivity of hydrophilic interaction chromatography (HILIC), J. Sep.

587

Ac ce p

585

Sci. 31 (2008) 1449–1464.

588

[43] N.S. Quiming, N.L. Denola, A.B. Soliev, Y. Saito, K. Jinno, Retention behavior of

589

ginsenosides on a poly(vinyl alcohol)-bonded stationary phase in hydrophilic

590

interaction chromatography, Anal. Bioanal. Chem. 389 (2007) 1477–1488.

591 592 593

[44] B. Dejaegher, D. Mangelings, Y. Vander Heyden, Method development for HILIC assays, J. Sep. Sci. 31 (2008) 1438–1448.

594

27

Page 27 of 60

595

[45] K. Kaczmarski, W. Prus, T. Kowalska, Adsorption/partition model of liquid

596

chromatography for chemically bonded stationary phases of the aliphatic cyano,

597

reversed-phase C8 and reversed-phase C18 types,

598

57–64.

ip t

J. Chromatogr. A 869 (2000)

[46] L. Rong, T. Takeuchi, Determination of iodide in seawater and edible salt by

600

microcolumn liquid chromatography with poly(ethylene glycol) stationary phase, J.

601

Chromatogr. A 1042 (2004) 131–135.

us

cr

599

[47] Z. Guo, Y. Jin, T. Liang, Y. Liu, Q. Xu, X. Liang, A. Lei, Synthesis, chromatographic

603

evaluation and hydrophilic interaction/reversed-phase mixed-mode behavior of a

604

"Click beta-cyclodextrin" stationary phase,

an

602

M

J. Chromatogr. A 1216 (2009) 257–263.

[48] Q. Fu, T. Liang, X. Zhang, Y. Du, Z. Guo, X. Liang, Carbohydrate separation by

606

hydrophilic interaction liquid chromatography on a 'click' maltose column,

607

Carbohydr. Res. 345 (2010) 2690–2697.

te

Ac ce p

608

d

605

609

[49] M. Xue, H. Huang, Y. Ke, C. Chu, Y. Jin, X. Liang, "Click dipeptide": a novel

610

stationary phase applied in two-dimensional liquid chromatography, J. Chromatogr. A

611 612

1216 (2009) 8623–8629.

613

[50] O. Núñez, K. Nakanishi, N. Tanaka, Preparation of monolithic silica columns for

614

high-performance liquid chromatography, J. Chromatogr. A 1191 (2008) 231–252.

615

[51] H. Lindner, B. Sarg, C. Meraner, W. Helliger, Separation of acetylated core histones

616

by hydrophilic-interaction liquid chromatography, J. Chromatogr. A 743 (1996)

617

137–144. 28

Page 28 of 60

618

[52] M. Lämmerhofer, M. Richter, J. Wu, R. Nogueira, W. Bicker, W. Lindner,

619

Mixed-mode ion-exchangers and their comparative chromatographic characterization

620

in reversed-phase and hydrophilic interaction chromatography elution modes,

621

Sci. 31 (2008) 2572–2588.

ip t

622

624

ion-exchange

high-performance

liquid

625

derivatization

and

by

626

chromatography-atmospheric

627

spectrometry,

confirmation

cr

[53] R.E. Hornish, J.R. Wiest, Quantitation of spectinomycin residues in bovine tissues by chromatography

reversed-phase chemical

an

pressure

with

us

623

J. Sep.

post-column

high-performance

ionization

tandem

liquid mass

J. Chromatogr. A 812 (1998) 123–133.

M

628

[54] S. He, Q.Y. Chen, Y. Sun, Y.C. Zhu, L.X. Luo, J.Q. Li, Y.S. Cao, Determination of

630

tobramycin in soil by HPLC with ultrasonic-assisted extraction and solid-phase

631

extraction, J. Chromatogr. B 879 (2011) 901–907.

te

d

629

Ac ce p

632 633

[55] M. Mashat, H. Chrystyn, B.J. Clark, K.H. Assi, Development and validation of HPLC

634

method for the determination of tobramycin in urine samples post-inhalation using

635 636 637

pre-column derivatization with fluorescein isothiocyanate, J. Chromatogr. B 869 (2008) 59–66.

638

[56] A. Posyniak, J. Zmudzki, J. Niedzielska, Sample preparation for residue determination

639

of gentamicin and neomycin by liquid chromatography, J. Chromatogr. A 914 (2001)

640

59–66.

641

29

Page 29 of 60

[57] P. Vinas, N. Balsalobre, M. Hernández-Córdoba, Liquid chromatography on an amide

643

stationary phase with post-column derivatization and fluorimetric detection for the

644

determination of streptomycin and dihydrostreptomycin in foods, Talanta 72 (2007)

645

808–812.

ip t

642

646

[58] V. Coquart, M.C. Hennion, Trace-level determination of polar phenolic compounds in

648

aqueous samples

liquid chromatography and

on-line

649

pre-concentration on porous graphitic carbon, J. Chromatogr. A 591 (1992) 195–201.

us

by high-performance

cr

647

[59] D.N. Heller, J.O. Peggins, C.B. Nochetto, M.L. Smith, O.A. Chiesa, K. Moulton,

651

LC-MS/MS measurement of gentamicin in bovine plasma, urine, milk, and biopsy

652

samples taken from kidneys of standing animals, J. Chromatogr. B 821 (2005) 22–30.

654

[60] M. Cherlet, S. De Baere, P. De Backer, Quantitative determination of

655

dihydrostreptomycin in bovine tissues and milk by liquid chromatography-

656

electrospray ionization-tandem mass spectrometry, J. Mass Spectrom. 42 (2007)

658

te

Ac ce p

657

d

653

M

an

650

647–656.

659

[61] R.H. Granja, A.M. Niño, R.A. Zucchetti, R. Patel, A.G. Salerno, Determination of

660

streptomycin residues in honey by liquid chromatography–tandem mass spectrometry,

661

Anal. Chim. Acta 637 (2009) 64–67.

662 663 664

[62] F.L. van Holthoon, M.L. Essers, P. J. Mulder, S.L. Stead, M. Caldow, H.M. Ashwin, M. Sharman, A generic method for the quantitative analysis of aminoglycosides (and

30

Page 30 of 60

665

spectinomycin) in animal tissue using methylated internal standards and liquid

666

chromatography tandem mass spectrometry, Anal. Chim. Acta 637 (2009) 135–143.

667

[63] H. Berrada, J.C. Moltó, J. Mañes, G. Font, Determination of aminoglycoside and

669

macrolide antibiotics in meat by pressurized liquid extraction and LC-ESI-MS, J. Sep.

670

Sci.

ip t

668

cr

33 (2010) 522–529.

[64] R. Ishii, M. Horie, W. Chan, J. MacNeil, Multi-residue quantitation of aminoglycoside

672

antibiotics in kidney and meat by liquid chromatography with tandem mass

673

spectrometry,

us

671

an

Food Addit. Contam. 25 (2008) 1509–1519.

[65] Y.F. Tao, D.M. Chen, H. Yu, L.L. Huang, Z.Y. Liu, X.Q. Cao, C.X. Yan, Y.H. Pan, Z.L.

675

Liu, Z.H. Yuan, Simultaneous determination of 15 aminoglycoside(s) residues in

676

animal

677

chromatography–tandem mass spectrometry, Food Chem. 135 (2012) 676–683.

foods

by

automated

solid-phase

extraction

and

liquid

te

d

derived

M

674

678

[66] A. Shen, L. Morgan, M.L. Barroso, X. Zhang, Method development of LC-MS/MS

680

analysis of aminoglycosides drugs: Challenges and solutions, Tandem Labs-Tuyen

681 682

Ac ce p

679

Nguyen; Sepracor Inc. (2008) 1–8.

683

[67] R. Oertel, V. Neumeister, W. Kirch, Hydrophilic interaction chromatography combined

684

with tandem-mass spectrometry to determine six aminoglycosides in serum, J.

685 686

Chromatogr. A 1058 (2004) 197–201. [68] R. Oertel, U. Renner, W. Kirch, Determination of neomycin by LC–tandem mass

687

spectrometry using hydrophilic interaction chromatography,

688

35 (2004) 633–638.

J. Pharm. Biomed. Anal.

31

Page 31 of 60

[69] K.M. Peru, S. L. Kuchta, J. V. Headley, A. J. Cessna, Development of a hydrophilic

690

interaction chromatography–mass spectrometry assay for spectinomycin and

691

lincomycin in liquid hog manure supernatant and run-off from cropland, J.

692

Chromatogr. A 1107 (2006) 152–158.

694

[70] D.A. Bohm, C.S. Stachel, P. Gowik, Confirmatory method for the determination of

cr

693

ip t

689

streptomycin in apples by LC–MS/MS, Anal. Chim. Acta 672 (2010) 103–106.

696

us

695

[71] A.M. Gremilogianni, N.C. Megoulas, M.A. Koupparis, Hydrophilic interaction vs ion pair

chromatography

for

the

determination

of

streptomycin

and

698

dihydrostreptomycin residues in milk based on mass spectrometric detection, J.

699

Chromatogr. A 1217 (2010) 6646–6651.

M

liquid

an

697

[72] P. Kumar, A. Rubies, R. Companyó, F. Centrich, Hydrophilic interaction

701

chromatography for the analysis of aminoglycosides, J. Sep. Sci. 35 (2012) 498–504.

te

d

700

702

[73] S.I. Kawano, Analysis of impurities in streptomycin and dihydrostreptomycin by

704

hydrophilic interaction chromatography/electrospray ionization quadrupole ion

705 706 707 708

Ac ce p

703

trap/time-of-flight mass spectrometry, Rapid Commun. Mass Spectrom. 23 (2009) 907–914.

[74] P. Kumar, A. Rúbies, R. Companyó, F. Centrich, Determination of aminoglycoside

709

residues

in

kidney

and

honey

samples

by

hydrophilic

interaction

710

chromatography-tandem mass spectrometry, J. Sep. Sci 35 (2012) 2710–2717.

711

32

Page 32 of 60

712

[75] W. Jiang, P. Appelblad, T. Jonsson, P. Hemström, Analysis of aminoglycosides with a

713

Zwitterionic

HILIC

Stationary

phase

714

Chromatography Today (2011) 26–28.

and

Mass

717

[76] A.C. Moffat, M.D. Osselton, B. Widdop, J. Watts, Clarke’s Analysis of Drugs and Poisons, Pharmaceutical Press, London, 2004.

cr

716

Detection,

ip t

715

Spectrometry

[77] B.C. McWhinney, S.C. Wallis, T. Hillister, J.A. Roberts, J. Lipman, J.P. Ungerer,

719

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet

720

detection, J. Chromatogr. B 878 (2010) 2039–2043.

an

us

718

721

[78] H. Liu, H. Wang, V.B. Sunderland, An isocratic ion exchange HPLC method for the

723

simultaneous determination of flucloxacillin and amoxicillin in a pharmaceutical

724

formulation for injection, J. Pharm. Biomed. Anal. 37 (2005) 395–398.

d

M

722

727

[79] M. Dousa, R. Hosmanová, Rapid determination of amoxicillin in premixes by HPLC,

Ac ce p

726

te

725

J. Pharm. Biomed. Anal. 37 (2005) 373–377.

728

[80] E. Benito-Peña, J.L. Urraca, M.C. Moreno-Bondi, Quantitative determination of

729

penicillin V and amoxicillin in feed samples by pressurized liquid extraction and

730 731

liquid chromatography with ultraviolet detection, J. Pharm. Biomed. Anal. 49 (2009) 289–294.

732

[81] E. Nemutlu, S. Kir, D. Katlan, M.S. Beksac, Simultaneous multiresponse optimization

733

of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid:

734

application to validation and quantification of cefepime, cefixime and cefoperazone,

735

Talanta 80 (2009) 117–126. 33

Page 33 of 60

736

[82] J.C. Garcia-Gonzalez, R. Méndez, J. Martin-Villacorta, Quantitative determination of

737

semisynthetic cephamycins

in

human serum

and

738

reversed-phase and ion-pair chromatography, J. Chromatogr. A 812 (1998) 197–204.

by ion-exchange,

ip t

739

urine

[83] C.M. Pistos, A. Tsantili-Kakoulidou, M. Koupparis, The effect of ion pairing reagents

741

in the retention profile of zwitterionic cephalosporins, J. Liq. Chromatogr. Related

742

Technol. 26 (2003) 937–952.

us

cr

740

743

[84] M.C. Rouan, F. Abadie, A. Leclerc, F. Juge, Systematic approach to the determination

745

of cephalosporins in biological fluids by reversed-phase liquid chromatography, J.

746

Chromatogr. 275 (1983) 133–144.

M

747

an

744

[85] I. Nishino, H. Fujitomo, T. Umeda, Determination of a new oral cephalosporin,

749

cefmatilen hydrochloride hydrate and its seven metabolites in human and animal

750

plasma and urine by coupled systems of ion-exchange and reversed-phase

752

te

Ac ce p

751

d

748

high-performance liquid chromatography, J. Chromatogr. B 749 (2000) 101–110.

753

[86] M.I. Bailón-Pérez, A.M. Garcia-Campaña, M. del Olmo-Iruela, L. Gámiz-Gracia, C.

754

Cruces-Blanco, Trace determination of 10 beta-lactam antibiotics in environmental

755 756

and food samples by capillary liquid chromatography, J. Chromatogr. A 1216 (2009) 8355–8361.

757 758 759

[87] M.A.

Strege,

S.

exchange/hydrophilic

Stevenson, interaction

S.M.

Lawrence,

liquid

Mixed-mode

anion-cation

chromatography-electrospray

mass

34

Page 34 of 60

760

spectrometry as an alternative to reversed phase for small molecule drug discovery,

761

Anal. Chem. 72 (2000) 4629–4633.

762

764

hydrophilic interaction chromatography,

765

623–628.

ip t

[88] Q. Liu, L. Xu, Y. Ke, Y. Jin, F. Zhang, X. Liang, Analysis of cephalosporins by J. Pharm. Biomed. Anal. 54 (2011)

766

[89] Y. Xu, W. Xie, C.M. Miller-Stein, E.J. Woolf,

Hydrophilic interaction

us

767

cr

763

chromatography/tandem mass spectrometry for the simultaneous determination of

769

three polar non-structurally related compounds, imipenem, cilastatin and an

770

investigational β-lactamase inhibitor, MK-4698, in biological matrices, Rapid

771

Commun. Mass Spectrom. 23 (2009) 2195–2205.

M

an

768

d

772

[90] S. Schiesel, M. Lämmerhofer, W. Lindner, Multitarget quantitative metabolic profiling

774

of hydrophilic metabolites in fermentation broths of β-lactam antibiotics production by

776 777 778 779

Ac ce p

775

te

773

HILIC-ESI-MS/MS, Anal. Bioanal. Chem. 396 (2010) 1655–1679.

[91] M. Jovanović, T. Rakić, B. Jančić-Stojanović, A. Malenović, D. Ivanović, M. Medenica,

Assessment

of

β-lactams

retention

in

hydrophilic

interaction

chromatography applying Box-Behnken design. J. Sep. Sci. 35 (2012) 1424–1431.

780 781 782

[92] H. Oka, Y. Ito, H. Matsumoto, Chromatographic analysis of tetracycline antibiotics in foods, J. Chromatogr. A 882 (2000) 109–133.

35

Page 35 of 60

783

[93] A. Marzo, L.D. Bo, Chromatography as an analytical tool for selected antibiotic

784

classes: a reappraisal addressed to pharmacokinetic applications, J. Chromatogr. A 812

785

(1998) 17–34.

ip t

787

[94] F.J. Schenck, P.S. Callery, Chromatographic methods of analysis of antibiotics in milk, J. Chromatogr. A 812 (1998) 99–109.

cr

786

788

[95] S. O’Connor, D.S. Aga, Analysis of tetracycline antibiotics in soil: Advances in

790

extraction, clean-up, and quantification, Trends Anal. Chem. 26 (2007) 456–465.

us

789

an

791

[96] M. Seifrtová, L. Novákova, C. Lino, A. Pena, P. Solich, An overview of analytical

793

methodologies for the determination of antibiotics in environmental waters, Anal.

794

Chim. Acta. 649 (2009) 158–179.

d

795

M

792

[97] M.S. Díaz-Cruz, D. Barceló, Recent advances in LC-MS residue analysis of veterinary

797

medicines in the terrestrial environment, Trends Anal. Chem. 26 (2007) 637–646.

799 800 801

Ac ce p

798

te

796

[98] R.P. Li, Y. Zhang, Y.P. Huang, Determination of Tetracycline Antibiotics in the Environmental Samples, Prog. Chem. 20 (2008) 2075–2082.

802

[99] H. Oka, K. Uno, K.I. Harada, K. Yasaka, M. Suzuki, Improvement of chemical

803

analysis of antibiotics: V. A simple method for the analysis of tetracyclines using

804

reversed-phase high-performance liquid chromatography, J. Chromatogr. A 298 (1984)

805

435–443.

36

Page 36 of 60

806

[100] E.J. Mulders, D.V. de Lagemaat, Determination of residues of tetracycline antibiotics

807

in animal tissues by high-performance liquid chromatography, J. Pharm. Biomed. Anal.

808

7(1989) 1829–1835. [101] J.R. Walsh, L.V. Walker, J.J. Webber, Determination of tetracyclines in bovine and

810

porcine muscle by high-performance liquid chromatography using solid-phase

811

extraction,

J. Chromatogr. A 596 (1992) 211–216.

us

812

cr

ip t

809

[102] C.R. Anderson, H.S. Rupp, W.H. Wu, Complexities in tetracycline analysis-chemistry,

814

matrix extraction, cleanup, and liquid chromatography, J. Chromatogr. A 1075 (2005)

815

23–32.

an

813

818

[103] J. Nawrocki, The Silanol Group and Its Role in Liquid Chromatography. J. Chromatogr. A 779 (1997) 29–71.

d

817

M

816

821 822 823

[104] K.K. Unger, R. Skudas, M.M. Schulte, Particle packed columns and monolithic

Ac ce p

820

te

819

columns in high-performance liquid chromatography-comparison and critical appraisal, J. Chromatogr. A 1184 (2008) 393–415.

824

[105] A.K. Sarmah, M.T. Meyer, A.B. Boxall, A global perspective on the use, sales,

825

exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the

826

environment, Chemosphere 65 (2006) 725–759.

827 828

[106] R.P. Li, Y. Zhang, C.C. Lee, Hydrophilic interaction chromatography separation

829

mechanisms of tetracyclines on amino-bonded silica column, J. Sep. Sci. 34 (2011)

830

1508–1516. 37

Page 37 of 60

831

[107] R. Li, Q. Yuan, Y. Zhang, J. Ling, T. Han, Hydrophilic interaction chromatographic

832

determination of oxytetracycline in the environmental water using silica column,

833

Liq. Chromatogr. & Rel. Technol. 34 (2011) 511–520.

J.

[108] J.C. Valette, C. Demesmay, J. L. Rocca, E. Verdon, Separation of Tetracycline

835

Antibiotics by Hydrophilic Interaction Chromatography Using an Amino-Propyl

836

Stationary Phase,

cr

ip t

834

Chromatographia 59 (2004) 55–60.

us

837

[109] R. Li, J. Huang, Chromatographic behavior of epirubicin and its analogues on

839

high-purity silica in hydrophilic interaction chromatography, J. Chromatogr. A 1041

840

(2004) 163–169.

an

838

M

841

[110] M.S.S Curren, J.W King, New sample preparation technique for the determination of

843

avoparcin in pressurized hot water extracts from kidney samples, J. Chromatogr. A

844

954 (2002) 41–49.

846 847 848

te

Ac ce p

845

d

842

[111] S. Van Dorpe, V. Vergote, A. Pezeshki, C. Burvenich, K. Peremans, B. De Spiegeleer, J. Sep. Sci. 33 (2010) 728 –739.

849

[112] M.M. Zheng, M.Y. Zhang, G.Y. Peng, Y.Q. Feng, Monitoring of sulfonamide

850

antibacterial residues in milk and egg by polymer monolith microextraction coupled to

851

hydrophilic interaction chromatography/mass spectrometry,

852

(2008) 160–172.

Anal. Chim. Acta 625

853 854 855

[113] G. Kesiunaite, E. Naujalis, A. Padarauskas, Matrix solid-phase dispersion extraction of carbadox

and

olaquindox

in

feed

followed

by

hydrophilic

interaction 38

Page 38 of 60

856

ultra-high-pressure liquid chromatographic analysis, J. Chromatogr. A 1209 (2008)

857

83–87. [114] K. Inoue, E. Yamada, T. Hino, H. Oka, Hydrophilic Interaction Liquid

859

Chromatography Tandem Mass Spectrometry Method for the Determination of

860

Bicozamycin in Milk, J. Liq. Chromatogr. & Rel. Technol. 32 (2009) 1914–1924.

cr

ip t

858

[115] H.Y. Ji, D.W. Jeong, Y.H. Kim, H.H. Kim, D.R. Sohn, H.S. Lee, Hydrophilic

862

interaction liquid chromatography-tandem mass spectrometry for the determination of

863

levofloxacin in human plasma, J. Pharm. Biomed. Anal. 41 (2006) 622–627.

an

us

861

864

[116] R.N. Rao, C.G. Naidu, K.G. Prasad, R. Padiya, S.B. Agwane, Determination of

866

gemifloxacin on dried blood spots by hydrophilic interaction liquid chromatography

867

with fluorescence detector: application to pharmacokinetics in rats, Biomed.

868

Chromatogr. 26 (2012) 1534–1542.

te

d

M

865

869

[117] H.D. Alwis, D.N. Heller, Multiclass, multiresidue method for the detection of

871

antibiotic residues in distillers grains by liquid chromatography and ion trap tandem

872 873

Ac ce p

870

mass spectrometry, J. Chromatogr. A 1217 (2010) 3076–3084.

874

[118] C. Chiaochan, U. Koesukwiwat, S. Yudthavorasit, N. Leepipatpiboon, Efficient

875

hydrophilic interaction liquid chromatography-tandem mass spectrometry for the

876

multiclass analysis of veterinary drugs in chicken muscle, Anal. Chim. Acta 682 (2010)

877

117–129.

39

Page 39 of 60

*Graphical Abstract

cr

Ion Chromatography

Normal Phase

ip t

Graphical Abstract

us

HILIC

Ac

ce pt

ed

M

an

Reversed Phase

Page 40 of 60

*Highlights (for review)

Highlights ► Use of HILIC for the analysis of antibiotics is reviewed. ► Specific applications of HILIC for different classes of antibiotics are discussed.

ip t

► ESI-MS/MS is the most popular detection method in HILIC separation of most antibiotics.

Ac

ce pt

ed

M

an

us

cr

► It provides comprehensive insight into HILIC application to antibiotics analysis.

Page 41 of 60

ip t

Table(s)

Packing materials

cr

Table 1 Summary of stationary phases used in HILIC separations [11]. Structure of stationary phase Siloxane

Silanol OH HO

siloxanes, silanols with (or without) a

Si

O

O

Si

OH

O

[12, 23]

Si

O

OH Si

derivatives

Diol bonded phases

Ac c

Amino bonded phases

ep te

Polymeric structures of poly (succinimide)

d

M

small quantity of metals

Si

OH

an

contain functional groups such as

us

Underivatized silica stationary phases that

Application

[23]

[23, 31]

[32]

Page 42 of 60

ip t cr an

us

Amide bonded phases

[34]

Mix-mode

Polyethylene

Ac c

Cyano bonded phases

ep te

d

M

Alkylamide

[23, 33]

glycol/silica (HS PEG)

[35]

[45]

[46]

Page 43 of 60

ip t cr

[47]

an

us

“click” ß-cyclodextrin

M

“click” saccharides

[48]

ep te

d

(“click” maltose)

Ac c

“click” dipeptide

[49]

Zwitterionic sulfobetaine

bonded phases (ZIC-HILIC)

[50]

Page 44 of 60

ip t cr

Cationic exchangers

us

bonded phases

an

Mix-mode RP/anionic exchangers bonded

[50, 52]

Ac c

ep te

d

M

phases

[51]

Page 45 of 60

ip t cr

Table 2 HILIC applications in the analysis of aminoglycosides Compound (s) of interest

Stationary phase

Kidney and muscle

Gentamicin/spectinomycin/dihydrostrept

tissues

omycin/kanamycin/apramycin/streptomy

Detection

Refs

ZIC-HILIC (SeQuant)

150 mM ammonium acetate +

ESI-MS

[64]

(100 mm x 2.1 mm, 5 µm)

1% FA-ACN; gradient

ACN-0.1% TFA; gradient

ESI-MS/MS

[65]

ESI-MS

[66]

ESI-MS/MS

[67]

an

M

cin/neomycin

Mobile phase

us

Matrix

Streptomycin/ amikacin/hygromycin

kidney, cow milk

B/dihydrostreptomycin/netilmicin/

and hen eggs

kasugamycin/ kanamycin B/ sisomicin/

CAPCELL PAK ST (150 mm x 2.0 mm, 3 µm)

ep te

d

Muscle, liver,

spectinomycin/ gentamicin

C1/apramycin/ paromomycin/

Ac c

tobramycin/ ribostamycin/neomycin B Mouse, Rat and

Amikacin/streptomycin/spectinomycin/ge ZIC-HILIC (SeQuant)

5 or 25 mM ammonium

Guinea Pig plasma

ntamicin

formate, pH 2.5-ACN - 1%

Human serum

(50 mm x 2.0 mm, 5 µm)

FA ; gradient

Amikacin/gentamicin/kanamycin/neomyc ZIC-HILIC

ACN-2 mM ammonium

in/paromomycin/ tobramycin

acetate- FA; gradient

(100 mm x 2.1 mm)

Page 46 of 60

ZIC-HILIC

ip t

Neomycin

[68]

APCI-MS/MS

[69]

ESI-MS/MS

[70]

ESI-MS

[71]

ESI-MS/MS

[72]

[73]

acetate- FA; gradient

(150 mm x 2.1 mm, 3 µm)

isocratic

Atlantis HILIC Silica

A: water + 0.05% FA /B:

(150 mm x 2.1 mm, 3 µm)

ACN + 0.05% FA; gradient

HILIC Fortis

150 mM ammonium formate-

(100 mm x 3.0 mm, 3 µm)

ACN, pH 4.5; gradient

Streptomycin/spectinomycin/dihydrostre

ZIC-HILIC

175 mM Ammonium formate ,

ptomycin/gentamicin C1/ gentamicin

(150 mm x 2.1 mm, 3.5

pH 4.5- 0.2% FA in ACN;

C1a/gentamicin C2/C2a/

µm)

gradient

Impurities in streptomycin and

Halo HILIC

100–200 mM ammonium

ESI-

dihydrostreptomycin

(100 mm x 2.1 mm, 2.7

formate, pH: 3.0–4.5-ACN;

QIT/TOFMS

µm)

isocratic

an

ACN-water-0.1% FA;

Streptomycin

Streptomycin/dihydrostreptomycin

ep te

Honey

ESI-MS/MS

Altima HP HILIC

d

Milk

Spectinomycin/lincomycin

M

Apples

us

(100 mm x 2.1 mm ) Manure

ACN-10 mM ammonium

cr

Human serum

Ac c

Apramycin/paromomycin/kanamycin A /neomycin B Bulk samples

FA : Formic acid; TFA: Trifluroacetic acid; QIT: Quadrupole ion trap

Page 47 of 60

Table 3 Comparison of the validation parameters of HILIC versus IPC method [71]. IPC method

STR

DHSTR

STR

DHSTR

LOQ

13.9 µg/kg

14 µg/kg

109 µg/kg

31 µg/kg

Recovery

85.5%

72.3%

69.3%

Inter-day precision

6.7–8.1%

9.8–11.2%

8.9–12.1% 9.7–13.4%

ip t

HILIC method

Ac

ce pt

ed

M

an

us

cr

56.5%

7

Page 48 of 60

ip t

Compound (s) of interest

Stationary phase

Mobile phase

Detection

Refs

Fermentation

2-Aminoadipic acid , 2-Amino-5-(4-carboxy-2-

ZIC-HILIC (and ZIC-

A: 10 % (v/v) 200

ESI-MS/MS

[88]

broths

thiazolyl)-valeric acid, 6-Aminopenicillanic acid,

HILIC Guard 20 mm x 2.1

mM FA, pH 4.0 in

6-Aminopenicilloic acid, 7-Aminocephalosporanic

mm; 5 µm)

water /B: 10 % (v/v)

A: 10 mM ammonium

UV/Vis ESI-

[89]

MS/MS

an

cr

Matrix

us

Table 4 Summary of beta-lactam antibiotics analyzed using HILIC with different detection systems

200 mM FA, pH 4.0

Cephalosporin C lactone, Deacetoxycephalosporin,

in ACN; gradient

M

acid, 8-Hydroxypenillic acid, Cephalosporin C,

Deacetylcephalosporin, Penicillamine disulfide,

d

Phenoxyacetic acid, Phenoxymethylpenicilloic

ep te

acid, Phenoxymethylpenillic acid, pHydroxyphenoxyacetic acid, δ-(L-αAminoadipoyl)-L-Cys-D-Val

Ceftazidime, cefixime, cefpiramide, ceftriaxone Atlantis HILIC silica

materials

sodium, cefotaxime sodium, cefazolin sodium, (100 mm x 2.1 mm, 5 µm)

formate, pH 6.8/B:

cefepime hydrochloride and degradation products Click β-CD column

ACN-100 mM

of cefotaxime sodium

ammonium formate,

Ac c

Raw

(150 mm x 2.1 mm, 5µm)

pH 6.8; gradient

8

Page 49 of 60

ip t

(50 mm x 2.1 mm, 3 µm)

Cefotaxime,

us

cefaclor,

cefuroxime, Alltech Silica

(250 mm x 4.6 mm, 5 µm)

[90]

UV/Vis

[91]

formate, pH 3 in 80% ACN; isocratic ACN-ammonium acetate, pH 4.5–6.5; isocratic

d

M

cefuroxime axetil, ampicillin and amoxicillin

an

cefalexin,

TIS-MS/MS

ep te

substances

lactamase inhibitor (BLI)

15 mM ammonium

Ac c

Reference

cr

Plasma, blood Imipenem (IMP), cilastatin (CIL), MK-4698 beta- Atlantis HILIC silica

9

Page 50 of 60

ip t Compound (s) of

Stationary phase

Detection Refs

ACN-6.7 mM ammonium citrate, pH

UV-Vis

[106]

UV-Vis

[107]

UV-Vis

[108]

UV-Vis

[109]

Mobile phase

us

Matrix

cr

Table 5 HILIC in the analysis of tetracylines antibiotics

interest OTC, TC, CTC,

Kromasil 100-5 NH2

water

doxycycline

(250 mm x 4.6 mm, 5 µm) 4.0 (85:15, v/v); isocratic

Environmental

OTC

Kromasil KR100-5SIL

M

ACN-10 mM oxalate, pH 2.5 (90:10,

(250 mm x 4.6 mm, 5 µm) v/v); isocratic ThermoHypersil APS2

ep te

TC, CTC, OTC

d

waters Drug substances

an

Environmental

ACN-6.7 mM citrate, pH 5.0 (85:15,

(50 mm x 4.6 mm, 3 µm)

v/v); isocratic

Epirubicin raw

Epidaunorubicin,

Kromasil KR100-5SIL

30 mM sodium formate, pH 2.9-ACN,

material

daunorubicin, epirubicin,

(250 mm x 4.6mm, 5 µm)

(90:10, v/v); isocratic

Ac c

doxorubicin

10

Page 51 of 60

ip t Compounds of interest

Stationary phase

Mobile phase

Detection

Refs

Kidney

Avoparcin

polyhydroxyethyl aspartamide

47% 15 mM Triethyl ammonium

UV

[110]

HILIC

phosphate in ACN; isocratic

[111]

an

us

Matrix

cr

Table 6 HILIC in the analysis of other antibiotics

(200 mm x 4.6 mm, 5 µm)

Sulfonamides antibacterial residues

Alltima HP HILIC

A: 0.1% w/v FA in ACN

Photodiode

(250 mm x 2.1 mm, 5 µm)

B: 0.1% w/v FA in water

array detector

Luna HILIC

ACN + 0.05% FA-water; gradient

ESI-MS

[112]

BEH HILIC

10 mM ammonium acetate in

Photodiode

[113]

(100 mm x 2.1 mm, 1.7 µm)

ACN -water (95:5, v/v); isocratic

array detector

TSK-Gel Amide 80

50 mM ammonium acetate in

ESI-MS/MS

[114]

(150 mm x 2.0 mm, 5 µm)

water (pH 4)-ACN; gradient

Atlantis HILIC Silica

ACN-100 mM ammonium

MS/MS

[115]

(50 mm x 3 mm, 5 µm )

formate , pH 6.5 (82:18 v/v);

Fluorescence

[116]

ESI-MS

[117]

M

Milk and eggs

Vancomycin and Polymyxin

d

Bulk substances

(150 mm x 2.0 mm, 3 µm)

Human plasma

Rat blood

Distillers grains

Bicozamycin

Levofloxacin

ep te

Milk

Carbadox and olaquindox

Ac c

Swine feed

Gemifloxacin

gradient ZIC-HILIC-C18

ACN -10 mM ammonium acetate

(100 mm x 4.6 mm, 5 µm)

(pH 3.5, 80:20, v/v); isocratic

Ampicillin, Penicillin G, OTC, TC,

Atlantic HILIC Silica

0.1% aqueous FA- ACN; gradient

CTC, Bacitracin A, Virginiamycin

(100 mm x 2.1 mm, 5 µm)

11

Page 52 of 60

ip t cr

Clarithromycin, Monensin A, STR ZIC–HILIC

β-lactams (3), lincosamides (2),

(2.1 mm x 100 mm, 3.5 µm)

macrolides (4), quinolones (4), sulfonamides (4) and tetracyclines

ESI-MS/MS

[118]

pH 2.5; B: ACN; gradient

ep te

d

M

(3)

A: 50 mM ammonium formate,

an

Aminoglycosides (3), amprolium,

Ac c

Chicken muscle

us

M1, Erythromycin A, Tylosin A,

12

Page 53 of 60

Figure(s)

ip t

High sensitivity

cr

HILIC

ESI-MS sensitivity

an

us

Reversed Phase

M

Normal Phase

Analyte Polarity

Apolar

Ac

ce pt

Polar

ed

Low sensitivity

Fig. 1

1 Page 54 of 60

Fig. 2

2

Page 55 of 60

ed

ce pt

Ac

us

an

M

ip t

Aqueous sublayer

cr

Polar stationary phase

Mostly organic mobile phase

ip t cr us an M ed ce pt Ac

Fig. 3

3 Page 56 of 60

ip t cr us an M ed ce pt Ac

Fig. 4

4 Page 57 of 60

ip t cr us an M ed ce pt Ac

Fig. 5

5 Page 58 of 60

ip t cr us an M d ep te Ac c

Fig. 6

6 Page 59 of 60

ip t R4

Teteracycline (TC)

H

OH

CH3

H

Chlortetracyclin (CTC)

H

OH

CH3

Cl

Oxytetracycline (OTC)

OH

OH

CH3

H

Doxycycline (DC)

H

H

CH3

cr

R3

us

R2

an

R1

Ac

ce pt

ed

M

H

Fig. 7

7 Page 60 of 60